BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 14, 2019
View Archived Issues
Identification of a novel target for the development of stroke treatments
Read More
Hitgen, Sun Pharma Advanced Research enter DEL-based drug discovery collaboration
Read More
Gene editing alleviates AD deficits in mouse models
Read More
China's NMPA clears HDAC6 inhibitor CS-3003 for phase I trials
Read More
Runx2 as a new target in chronic rhinosinusitis with neo-osteogenesis
Read More
AAV delivery of EPO-R76E delays retinal degeneration in a mouse model of geographic atrophy
Read More
Discovery of the first selective inhibitor of group XVI phospholipase A2
Read More
ACAM is a potential molecular target for treating multiple sclerosis
Read More
Identification of pyrrolidine amide derivatives as novel N-acylethanolamine acid amidase inhibitors
Read More
Results on safety, tolerability and pharmacokinetics of benapenem in healthy volunteers
Read More
Discovery of a druggable mechanism underlying tumorigenesis in ovarian cancer
Read More
RGC-32 as new target in chronic multiple sclerosis
Read More
Apelin receptor agonists identified at Bristol-Myers Squibb
Read More
Amgen presents new Mcl-1 inhibitors
Read More
Identification of a biomarker of inflammatory bowel disease severity
Read More
Wee1-like protein kinase inhibitors patented by Shanghai De Novo Pharmatech
Read More
Selection Bioscience discloses androgen receptor antagonists
Read More
Development of a novel, selective, kappa-opioid receptor antagonist
Read More
JS Innopharm patents ERK-2 inhibitors
Read More
AbbVie initiates phase I study of alpha-synuclein-targeting antibody ABBV-0805 for Parkinson's
Read More
Kyowa Hakko Kirin begins phase I study of KHK-4323 for atopic dermatitis
Read More
LRP-1 targeting confers retinal neuroprotection in diabetic mice
Read More
Phase III VELOS-2 trial explores use of HL-036 in patients with dry eye
Read More
BrainStorm initiates phase II study of MSC-NTF cells in progressive MS
Read More
Biohaven initiates phase III trial of troriluzole for spinocerebellar ataxia
Read More
Infinity and Roche enter master clinical supply agreement for MARIO-3 combination trial of IPI-549
Read More